Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer

Pancreatobiliary Cancer Study Group of Korean Society of Gastrointestinal Cancer

    Research output: Contribution to journalArticlepeer-review

    17 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences